08:00 , Dec 16, 2013 |  BC Week In Review  |  Clinical News

BGM Galectin-3 test regulatory update

BG Medicine said the Centers for Medicare and Medicaid Services (CMS) issued a final decision to set the 2014 payment rate at $30.01 for its BGM Galectin-3 test, which is approved as an aid for...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Clinical News

BGM Galectin-3 test regulatory update

BG Medicine said the Centers for Medicare and Medicaid Services (CMS) issued a preliminary decision to set the 2014 payment rate at $30.24 for its BGM Galectin-3 test as an aid for assessing the prognosis...
07:00 , Apr 1, 2013 |  BC Week In Review  |  Clinical News

BGM Galectin-3 test regulatory update

BG Medicine disclosed in its 2012 earnings that it allowed its 510(k) application to expire for the BGM Galectin-3 test for assessing the risk of developing new-onset heart failure. The company said it is evaluating...